TTOO vs. ICU, MDAI, NMTC, FEMY, AKLI, IINN, RVP, GBS, CODX, and NEPH
Should you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include SeaStar Medical (ICU), Spectral AI (MDAI), NeuroOne Medical Technologies (NMTC), Femasys (FEMY), Akili (AKLI), Inspira Technologies Oxy B.H.N. (IINN), Retractable Technologies (RVP), GBS (GBS), Co-Diagnostics (CODX), and Nephros (NEPH). These companies are all part of the "surgical & medical instruments" industry.
SeaStar Medical (NASDAQ:ICU) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.
1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 3.0% of SeaStar Medical shares are owned by company insiders. Comparatively, 0.1% of T2 Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
T2 Biosystems received 405 more outperform votes than SeaStar Medical when rated by MarketBeat users. However, 100.00% of users gave SeaStar Medical an outperform vote while only 64.65% of users gave T2 Biosystems an outperform vote.
SeaStar Medical has a beta of -0.96, indicating that its stock price is 196% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.05, indicating that its stock price is 95% less volatile than the S&P 500.
SeaStar Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -636.09%.
In the previous week, T2 Biosystems had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 5 mentions for T2 Biosystems and 4 mentions for SeaStar Medical. T2 Biosystems' average media sentiment score of 0.78 beat SeaStar Medical's score of 0.75 indicating that SeaStar Medical is being referred to more favorably in the media.
SeaStar Medical has higher earnings, but lower revenue than T2 Biosystems.
T2 Biosystems has a consensus target price of $3.00, suggesting a potential downside of 43.93%. Given SeaStar Medical's higher probable upside, analysts clearly believe T2 Biosystems is more favorable than SeaStar Medical.
Summary
T2 Biosystems beats SeaStar Medical on 7 of the 12 factors compared between the two stocks.
Get T2 Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TTOO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
T2 Biosystems Competitors List
Related Companies and Tools
